Response by Pleva et al to Letter Regarding Article, "Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study"
Circ Cardiovasc Interv
.
2016 Sep;9(9):e004304.
doi: 10.1161/CIRCINTERVENTIONS.116.004304.
Authors
Leos Pleva
1
,
Pavel Kukla
1
,
Pavlina Kusnierova
2
,
Jana Zapletalova
3
,
Ota Hlinomaz
4
Affiliations
1
Department of Cardiovascular Diseases, University Hospital Ostrava, Czech Republic.
2
Department of Laboratory Medicine, University Hospital Ostrava, Czech Republic.
3
Department of Medical Biophysics, Palacky University, Olomouc, Czech Republic.
4
International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
PMID:
27613770
DOI:
10.1161/CIRCINTERVENTIONS.116.004304
No abstract available
Publication types
Letter
Comment
MeSH terms
Angioplasty, Balloon, Coronary
Coronary Angiography
Coronary Restenosis
Drug-Eluting Stents
Everolimus*
Humans
Paclitaxel*
Sirolimus
Stents
Treatment Outcome
Substances
Everolimus
Paclitaxel
Sirolimus